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Prenatal AMA diagnosis has traditionally been performed 
by cytogenetic analysis of cultured fetal cells, which is time-
consuming (7 - 21 days) and expensive (R2 400, NHLS rate). 
Quantitative fluorescent polymerase chain reaction (QF-PCR) 
analysis is now recognised as a viable alternative to cytogenetic 
analysis for the rapid detection of autosomal aneuploides.1
QF-PCR is a molecular (DNA)-based test performed on 
uncultured fetal cells. Used in the Laboratory of the Division 
of Human Genetics it is able to detect the common numerical 
chromosomal abnormalities of chromosomes 21, 18, 13, X 
and Y. Trisomies 13, 18 and 21 are detected with about 99% 
accuracy, usually within 48 - 72 hours and at a cost of R1 197 
(NHLS rate).
QF-PCR has limitations. It cannot yield accurate results 
when there is maternal contamination of amniotic fluid or, less 
commonly, when chromosomal imbalances such as low-level 
mosaicism (<30%), some types of polyploidy, and structural 
chromosomal abnormalities (deletions, translocations and 
ring chromosomes) are present. It detects extra chromosome 
21 material present in cells with unbalanced translocations 
of chromosome 21, but does not identify the problem as a 
translocation. These shortcomings are, however, put into 
perspective by a multi-centre audit of 23 genetic laboratories, 
which found that, in over 98 000 amniocenteses performed 
after Down syndrome screening, only about 1% of autosomal 
chromosome abnormalities were not detectable by QF-PCR.2
In industrialised countries, newer technologies such as QF-
PCR are considered as optional extras to routine cytogenetic 
analysis for prenatal diagnosis.1 However, in resource-limited 
developing nations such as South Africa, we believe that QF-
PCR can be the standard diagnostic technique.
Therefore, at the Division of Human Genetics, QF-PCR will 
now be done instead of conventional cytogenetic analysis in 
cases where AMA is the only indication. Should abnormalities 
be detected on sonar or other specific indications, full 
karyotyping can still be requested and performed. Pretest 
counselling of AMA women should take this policy change 
into consideration; a pro forma consent form for amniocentesis 
that does so, is available from the Division of Human Genetics.
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Of HIV, grief and TOP
To the Editor: People living with HIV are frequently people 
living with very high levels of grief. They grieve over the loss 
of life expectancy and of their own dreams for the future. They 
are often grieving over the loss of a spouse or a child. In our 
practice, they are frequently grieving over the loss of other 
close relatives. This makes them emotionally very vulnerable 
people.
At first sight, the offer of TOP to such people in early 
pregnancy may seem to be a compassionate way to avoid 
further grief from infant losses, and to avoid increasing the 
number of orphans in our nation. Yet there is strong evidence 
that a decision for TOP may precipitate a severe grief reaction 
of its own. Such grief has been associated with a 7-fold increase 
in suicide and homicide,1 and a 180% increase in psychiatric 
illness, in the year following TOP in first-world countries 
with excellent access to health care.2,3 In South Africa, with 
the generally poor access to psychiatric care and high levels 
of violence, the effects can be expected to be far greater. The 
effects of maternal depression, of resorting to substance abuse 
or of the development of self-destructive behaviour, may 
completely negate the advantages to the family of not having 
another baby to nurture.
This question raises the need for very skilled and careful 
counselling of women with HIV before TOP is offered, and 
very careful follow-up and emotional support following TOP, 
should they choose that option. It also makes even stronger the 
case for ready access to HAART.
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